<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00406185</url>
  </required_header>
  <id_info>
    <org_study_id>128-db1</org_study_id>
    <nct_id>NCT00406185</nct_id>
  </id_info>
  <brief_title>Database Registry of the Intermountain Heart Collaborative Study</brief_title>
  <official_title>Database Registry of the Intermountain Heart Collaborative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intermountain Health Care, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intermountain Health Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the registry is to collect and analyze clinical and laboratory data and tissue&#xD;
      samples from patients who are diagnosed with any type of heart disease and to collect the&#xD;
      same information and samples from healthy controls in participating Intermountain Healthcare&#xD;
      facilities.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a registry (database) project; there are no investigational treatments, drug or&#xD;
      procedures associated with participation in registry activities. This project is an organized&#xD;
      data gathering and storing (database) endeavor with specific focus on the precursors,&#xD;
      modifiers, biological, and genetic parameters of heart disease and related medical&#xD;
      conditions. Data collection will not immediately influence the course of treatment for any&#xD;
      patient.Sample testing and data utilization for basic science, clinical, and epidemiologic&#xD;
      and publication projects can be initiated using the databank.&#xD;
&#xD;
      The registry will enable researchers to determine best medical practices for predicting,&#xD;
      preventing, and treating heart disease. The registry will: 1) develop standard methods to&#xD;
      collect data and specimens which will be used for research to characterize patients diagnosed&#xD;
      with heart disease as well as healthy controls and to assess differences in demographics and&#xD;
      patient outcomes in both populations; 2) collect, process, and store patients' clinical data&#xD;
      and tissue/blood samples; 3) analyze data collected; 4) use these resources to identify&#xD;
      genes, genetic polymorphisms, genetic mutations, clinical methods and procedures, and/or&#xD;
      biomarkers that predict, prevent, or treat heart disease and/or are associated correlate with&#xD;
      lifestyle or disease outcomes; 5) publish and disseminate results.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 1994</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outcome Risk</measure>
    <time_frame>30 years</time_frame>
    <description>To evaluate risk factors, characteristics, and treatments to cardiovascular outcomes</description>
  </primary_outcome>
  <enrollment type="Anticipated">30000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Electrophysiology</condition>
  <condition>Cardiovascular Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing a procedure within the catheterization laboratory&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The patient (male or non-pregnant female) must be &gt; 18 years of age.&#xD;
&#xD;
          2. The patient or legally authorized representative must sign a written informed consent,&#xD;
             prior to the procedure, using a form that is approved by the local Institutional&#xD;
             Review Board.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Neither patient nor patient representative understands spoken English.&#xD;
&#xD;
          2. Neither patient nor the patient's personal representative is willing to give written&#xD;
             consent for participation.&#xD;
&#xD;
          3. Healthy control patients must sign their own consent document.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph B Muhlestein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intermountain Healthcare, LDS Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Taylor GS, Muhlestein JB, Wagner GS, Bair TL, Li P, Anderson JL. Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J. 1998 Nov;136(5):792-803.</citation>
    <PMID>9812073</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 30, 2006</study_first_submitted>
  <study_first_submitted_qc>November 30, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2006</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Registry</keyword>
  <keyword>cardiac catheterization laboratory</keyword>
  <keyword>coronary heart disease</keyword>
  <keyword>cardiovascular disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

